Florida Surgeon General Cites Debunked Claims In Calling For Halt Of COVID Shots
Federal health officials, as well as other medical experts, have dismissed Dr. Joseph Ladapo’s concerns as factually inaccurate and dangerous to human health.
Federal health officials, as well as other medical experts, have dismissed Dr. Joseph Ladapo’s concerns as factually inaccurate and dangerous to human health.
George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed insurance coverage and a handful of unpleasant side effects. …
Woman’s waist size may be contributing factor to infertility, study says Woman’s waist size may be contributing factor to infertility, study says 00:53 BOSTON – One in four couples struggle with infertility and a new study finds that a woman’s waist size may be a contributing factor. A team in China studied more than 3,000…
Health 11 July 2023, 5:39 pm 1 minute Reuters exclusively reported that Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s (NOVOb.CO) Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply. Market Impact Shares of the Danish drugmaker fell 2.3% on Tuesday. Article…
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. When the average person thinks about combating climate change, their…
For those who aren’t vaccinated against COVID-19, probiotics could offer a level of protection against the virus, a new study suggests. In a randomized, placebo-controlled study led by Duke Health in North Carolina, probiotics were shown to have a “significant ability to delay a COVID infection and reduce symptoms” among people who had not been…
Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer…